There is increasing interest in the role of nitric oxide (NO) in common metabolic disorders such as type 2 diabetes (T2D). The underlying mechanisms by which theses complications arise and manifest remain poorly understood. Investigators have demonstrated that some of the changes that occur as a result of the diabetic environment include reduced bioavailability of NO 7 . NO originates via the oxidative L-arginine pathway catalyzed by a NO-synthase (NOS) family constituted by three distinct NOS isoforms (EC. 1.14.13.39). Neuronal and endothelial NOS (also designated NOS1 and NOS3) were identified in and cloned from neuronal and endothelial cells, respectively, whereas inducible NOS was isolated originally from activated macrophages and was therefore called macrophage NOS (also designated NOS2). Muscle fibre-type specific NOS expression in healthy skeletal muscles is profoundly described 1, 8 . We have earlier reported that NOS immunoreactivity was found to be associated primarily with fast-oxidative glycolytic (FOG) muscle fibres 8, 9 . However, studies about fibre related NOS expression in skeletal muscles from T2D patients are missing.
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Aim of the present study was to investigate the NOS1-3 expression in the vastus lateralis muscles of T2D patients in comparison to healthy individuals with NGT and to show a relationship of NOS1-3 to defined fibre types. The muscle fibres were typed according to three classification systems as slow and fast (physiological fibre types), as I, IIA, IIX (myosin based ATPase fibre types) and as SO (slow oxidative), FOG (fast oxidative glycolytic) and FG (fast glycolytic; physiological-metabolic fibre types). We measured NOS expression in defined muscle fibres in situ cytophotometrically and in the muscle homogenate by Western blotting.
Anthropometric and metabolic characteristics of subjects are summarized in Table 1 .
Age, sex distribution and anthropometric parameters were not significantly different between the NGT and T2D groups. In parallel with the altered parameters of glucose metabolism and insulin sensitivity, maximal aerobic capacity (VO 2max ) was significantly lower in the T2D
group. The analysis of vastus lateralis muscle biopsies revealed that all three NOS isoforms were co-localized in the same fibres as evidenced from examination of adjacent immunolabelled sections, illustrated in Fig. 1 In this study, we found a co-expression of NOS 1-3 in the metabolic defined fibre subtypes of FOG. This agrees with our earlier findings in skeletal muscles of healthy subjects 8 , patients with type 1 diabetes (T1D) 10 and patients with Duchenne muscular dystrophy 9, 11 .
The correlation of NOS expression to the myosin-based ATPase fibre types was not obvious due to their metabolic heterogeneity. However, NOS1-3-positive fibres were clearly defined as FOG fibres. We have previously demonstrated that fast fibres without or very low oxidative metabolism fast glycolytic (FG) fibres were NOS-negative 8 . This implies that NO as modulator of muscle functions is involved in oxidative metabolism in connection with fast force development, which only occurs in FOG fibres. Therefore, we confirm here the distinct role of FOG fibres in muscle function already suggested in our earlier studies 12 .
Cytophotometrical assessment of NOS1-3 immunoreactivity showed no significant differences between T2D and NGT subjects (Fig. 4) . Our findings that the expression of all three NOS isoforms in skeletal muscles does not significantly differs between NGT and T2D individuals are in accordance with the report of Kashyap et al. 13, 14 who did not found any differences in NOS protein content in muscle homogenates of healthy and T2D individuals.
In contrast to T2D patients, we measured reduced expression of NOS 1-3 expression in skeletal muscle of T1D patients, compared to NGT subjects 10 . These alterations could be linked to the reduction of FOG fibres 10 and the lack of C-peptid 15 . In muscles of T2D patients, frequency of FOG fibres and C-peptid level were not significantly changed, in contrast to T1D 6, 15 . In both T1D and T2D, chronic hyperglycemia occurs, the insulin sensitivity is preserved in T1D and impaired in T2D. This suggests that hyperglycemia and impaired insulin sensitivity do not effect the NOS expression in skeletal muscle fibres.
Notably, the NO levels in quadriceps muscle of T2D patients were earlier reported to be significantly higher than in healthy controls 16 . In this study, we show that the NOS expression in FOG fibres does not significantly differ between NGT and T2D individuals.
This poses a question; why total NO plasma levels in T2D patients are nevertheless significantly lower compared with healthy controls 17 . The apparent inconsistency can be explained by an increased oxidative stress in diabetes 16, 18 resulting in withdrawing NO from its regular physiological course via the scavenging actions of superoxides. Consequently, the NO bioavailability gets drastically reduced 19 . As a result, the cell is getting short of bioactive 
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Figure legends

Methods
Subjects and muscle biopsies
Muscle biopsies were obtained from 25 Caucasian men (n = 12) and women (n = 13) that have been divided into 15 subjects (8 male and 7 female) with normal glucose tolerance (NGT) and 10 patients (4 male and 6 female) with type 2 diabetes (T2D). The diagnosis of NGT and T2D was based on oral glucose tolerance tests (OGTT) following the ADA-criteria 21 . Patients with malignant diseases or any acute or chronic inflammatory disease as determined by a leucocyte count > 7000 Gpt/l, C-reactive protein (CrP) > 5.0 mg/dl, or clinical signs of infection were excluded from the study. The study was approved by the ethics committee of the University of Leipzig. All subjects gave written informed consent before taking part in the study. Body mass index (BMI) was calculated as weight (in kilograms) divided by the square of height (in meters). Waist and hip circumferences were measured and waist-to-hip ratio (WHR) was calculated. Percentage body fat was measured by dual-energy X-ray absorptiometry (DEXA). All subjects completed a graded bicycleergometer test to volitional exhaustion and had maximal oxygen uptake measured with an automated open circuit gas analysis system at baseline. The highest oxygen uptake/minute reached was defined as the maximal oxygen uptake (VO 2 max). Participants were admitted into the study at 9 am after 14 hours of fasting. They had been asked to avoid vigorous exercise for at least 3 days before the muscle biopsy. After administration of local anesthesia, muscle biopsy specimens were obtained from the vastus lateralis muscle using a biopsy device (SOMATEX, Teltow, Germany). Muscle samples were powdered with talcum and immediately frozen in liquid nitrogen. The samples were diveded into two parts. One of the pieces was used for Western blotting, the other was transferred into a cryostat 1800 (Reichert Jung, Vienna, Austria). 10 µm thick cross sections were cut which were used for enzyme histochemical and immunohistochemical analysis. To avoid possible variations in section thickness and incubation conditions, samples of NGT and T2D were mounted together on a cryostat chuck.
Enzyme histochemistry
Activity of succinate dehydrogenase (SDH, E.C. 1.3.5.1) was measured according to Lojda and Gutmann 22 . In a modified way, the method of Lojda and Gutmann 22 was used to demonstrate activity of mitochondrial glycerol-3-phosphate dehydrogenase (GPDH, E.C. 
Myosin heavy chain (MHC) isoforms-Immunohistochemistry
Mouse monoclonal antibodies against slow and fast MHC isoforms were used following the guidelines recommended by the manufacturers (Novocastra Laboratories Ltd, Newcastle, UK). In brief, serial sections were incubated with the primary MABs 60 min at 37° C followed by incubation with rabbit-anti-mouse secondary AB (Jackson Immuno Research Laboratories, Inc, USA) for 60 min at 37°C and mouse PAP-complex (Jackson Immuno
Research Laboratories, Inc, USA) 60 min at room temperature. The visualization was performed by incubation with 3,3-diaminobenzidine. After dehydration, the sections were mounted in Entellan (Merck, Darmstadt, Germany).
Fiber typing
Fibres were typed into slow and fast according to their slow or fast MHC-isoforms detected (fast oxidative glycolytic) and FG (fast glycolytic) has been described previously (Punkt 2002 ), based on cytophotometrically quantified activities of SDH (marker of oxidative activity) and GPDH (marker of glycolytic activity) and the immunoreactivity against slow and fast myosin in serial cross sections of the same fibre. SO fibres showed high SDH and low GPDH activity, FG fibres showed high GPDH and very low SDH activity. FOG fibres were subdivided into FOG I (moderate SDH and high GPDH activity) and FOG II (high SDH and moderate GPDH activity).
Cytophotometry
End-point measurements were performed with a computer-controlled microscope photometer MPM 200 with a scanning table (Carl Zeiss, Oberkochen, Germany). The absorbance of the NOS-immunostained muscle fibres of NGT and T2D muscles arranged arranged in pairs on the same glass slide were measured. Three sections per muscle biopsy were evaluated. By mounting samples of NGT and T2D muscles on one and the same cryostat chuck the sections to compare were subjected the same cutting step and identical staining conditions. Differences in absorbance data between NGT and T2D muscle fibres reflect changes in NOS immunoreactivity in T2D muscles.
NOS-Immunohistochemistry
Cryostat sections were fixed in cold acetone for 15 min and thoroughly air dried for 30 min.
After rinsing in PBS, nonspecific binding sites were blocked by incubation in PBS containing 10% goat serum for 30 min. PBS was used for all rinses and dilutions. Cryostat sections were incubated overnight at 4°C with rabbit primary polyclonal Abs recognizing NOS 1, NOS 2, NOS 3 (Transduction Laboratories, Lexington, KY). Primary Ab was diluted to a final concentration of 1.0 μg/ml. To quench endogeneous peroxidase activity, sections were treated with methanol containing 1.2% H 2 O 2 for 15 min. Bound primary Abs were detected by employing horse radish peroxidase-conjugated goat-anti-rabbit secondary Abs which was followed by tyramide signal amplification (TSA-kit, NEN, Cologne, Germany) and ABC technique using the Vectastain ABC-kit (Vector Laboratories, USA). The visualization was performed using NovaRed substrate kit for peroxidase (Vector). The reaction was observed under the microscope and was stopped by rinsing with water after 4-10 minutes. Control incubations were: i) omission of primary Ab; and ii) substitution of primary Ab by rabbit IgG (Dianova, Hamburg, Germany) at the same final concentration as the primary Ab.
NOS-Western blotting
Total protein of skeletal muscle biopsies harvested in PBS and sedimented by centrifugation was homogenized in 10 mM Hepes (pH 7.5) containing 0.2 mM phenylmethylsulfonylfluoride (PMSF) and 0.1 mM dithiothreitol (DTT) using an Ultra Turrax (IK, Staufen, Germany) at 30.000 rpm for 3x5 sec. The final pellet was suspended in 0.75 ml 
